Viral contaminations only rarely occur in the biopharmaceutical industry. However, they present a serious threat as they are difficult to detect and there is a lack of effective methods of treating infected cell cultures. Therefore, viral contaminations should be prevented as much as possible and raw materials, cell banks and products should be regularly checked for the presence of viruses.
BaseClear Quality Solutions has developed a special service for viral testing. We can detect and characterize not only known viral pathogens, but also novel ones from a wide spectrum of sample types. Therefore, we will isolate the viral RNA or DNA from your samples, and sequence it using next generation sequencing (NGS) technology.
Richard is director of the Sanger sequencing and microbiology department. In addition he is site-manager of ProBase Pharma, the joint venture of BaseClear and MicroSafe for GMP accredited rapid molecular testing.
CONVINCED? GET IN TOUCH
Get a quote